Related Experiment Video

Updated: Apr 10, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

1.3K

Gout and a Subsequent Increased Risk of Erectile Dysfunction in Men Aged 64 and Under: A Nationwide Cohort Study in

Yung-Fu Chen1, Hsuan-Hung Lin1, Chuan-Chin Lu1

  • 1From the Department of Healthcare Administration, and Department of Dental Technology and Materials Science, and Department of Management Information Systems, Central Taiwan University of Science and Technology; Department of Health Services Administration, China Medical University; Department of Physical Therapy, Hungkuang University, Taichung; Department of Urology, Feng Yuan Hospital, Ministry of Health and Welfare; Department of Internal Medicine, Taichung Hospital, Ministry of Health and Welfare, Taichung; Department of Rheumatology, Nantou Hospital, Ministry of Health and Welfare, Nantou; Department of Family Medicine, and Department of Medical Education, Puli Christian Hospital, Nantou, Taiwan.Y.F. Chen, PhD, Department of Healthcare Administration, and Department of Dental Technology and Materials Science, Central Taiwan University of Science and Technology, and Department of Health Services Administration, China Medical University; H.H. Lin, PhD, Department of Management Information Systems, Central Taiwan University of Science and Technology; C.C. Lu, MD, Department of Rheumatology, Nantou Hospital, Ministry of Health and Welfare, and Department of Physical Therapy, Hungkuang University; C.T. Hung, PhD, Department of Healthcare Administration, Central Taiwan University of Science and Technology; M.H. Lee, MD, Department of Urology, Feng Yuan Hospital, Ministry of Health and Welfare; C.Y. Hsu, MD, PhD, Department of Family Medicine, and Department of Medical Education, Puli Christian Hospital; W.S. Chung, MD, PhD, Department of Healthcare Administration, Central Taiwan University of Science and Technology, and Department of Health Services Administration, China Medical University, and Department of Internal Medicine, Taichung Hospital, Ministry of Health and Welfare.

The Journal of Rheumatology
|June 17, 2015
PubMed
Abstract

Keywords:
ERECTILE DYSFUNCTIONGOUTPOPULATION-BASED COHORT STUDY

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.5K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
326
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
351
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
341
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
816
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
331